investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Pinar Ozden Eser

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Pinar Ozden Eser

Harvard University

Cambridge, United States

Related projects

Martin Mcintosh

Profiling cancer neoantigen repertoires and validating immunotherapy targets

Trachea, bronchus and lung

Giovanna Tosato

A Role for KSHV in the Pathogenesis of Malignancies

Trachea, bronchus and lung

Pathology Hematology and hematologic malignancies

Saikrishna Yendamuri

MicroRNA profiling to predict recurrence after resection of early lung cancer

Trachea, bronchus and lung

Jeffrey Mackeigan

Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer

Trachea, bronchus and lung

Pathology

Allan Weissman

Determining the Fate of Transmembrane Proteins

Trachea, bronchus and lung

Jennifer Brady

Mechanisms governing tumor differentiation and metastasis

Trachea, bronchus and lung

Pathology

Tyshia Kyree Gwin

Induction of tumor suppressor p16INK4A by human papillomavirus 16 E7 oncoprotein

Trachea, bronchus and lung

Pasi A Janne

Drug Resistance in Lung Cancer

Trachea, bronchus and lung

Uwe Rix

Harnessing beneficial off-target effects of kinase inhibitors in lung cancer

Trachea, bronchus and lung

Pathology